Literature DB >> 15851218

Transient atrioventricular conduction block with cryoablation following normal cryomapping.

Peter S Fischbach1, Elizabeth V Saarel, MacDonald Dick.   

Abstract

OBJECTIVES: The purpose of this study was to demonstrate that adverse but reversible effects on AV conduction may be observed during cryoablation despite no evidence of deleterious effects evident during cryomapping.
BACKGROUND: Transcatheter cryoablation has recently been introduced for treatment of supraventricular tachycardia. Potential advantages compared with radiofrequency ablation include decreased risk of thromboembolism and perforation, less patient discomfort, more sharply demarcated lesions, and decreased risk of inadvertent damage to adjacent structures due to the ability to observe the electrophysiologic effects of lesion generation prior to permanent tissue damage. Occasionally, however, adverse electrophysiologic effects may be observed during cryoablation when prior cryomapping suggests a safe location.
METHODS: We reviewed the experience with our first 32 consecutive patients who underwent cryoablation for supraventricular tachycardia. Patients who experienced transient heart block during cryoablation following uneventful cryomapping were identified.
RESULTS: Five patients in whom cryomapping was performed with no evidence for deleterious effects on AV conduction were identified. However, application of cryoablation at these mapped sites resulted in transient complete heart block. This experience demonstrates that the cryolesion created during cryoablation may expand relative to that suggested by cryomapping.
CONCLUSIONS: It is important to maintain vigilance in monitoring for AV nodal conduction abnormalities during cryoablation, even when cryomapping suggests a safe location for cryoablation.

Entities:  

Mesh:

Year:  2004        PMID: 15851218     DOI: 10.1016/j.hrthm.2004.06.018

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  8 in total

1.  Slow pathway ablation in a 5-year-old boy with atrioventricular septal defect: value of cryoenergy application.

Authors:  T Kriebel; H Schneider; M Sigler; T Paul
Journal:  Clin Res Cardiol       Date:  2006-09-28       Impact factor: 5.460

2.  Cryomap failure.

Authors:  Vikram K Reddy; Roger Villuendas; Andrew Rudin; Jeffrey J Goldberger; Alan H Kadish
Journal:  J Interv Card Electrophysiol       Date:  2007-08-01       Impact factor: 1.900

3.  Transcatheter cryotherapy for the treatment of supraventricular tachyarrhythmias in children: a single center experience.

Authors:  Andrew L Papez; Mohamad Al-Ahdab; Macdonald Dick; Peter S Fischbach
Journal:  J Interv Card Electrophysiol       Date:  2006-08-17       Impact factor: 1.900

4.  Cryoablation therapy for atrioventricular nodal reentrant tachycardia in children: a multicenter experience of efficacy.

Authors:  Srikant Das; Ian H Law; Nicholas H Von Bergen; David J Bradley; Macdonald Dick; Susan P Etheridge; Elizabeth V Saarel; Patricio A Frias; Margaret J Strieper; Peter S Fischbach
Journal:  Pediatr Cardiol       Date:  2012-03-20       Impact factor: 1.655

Review 5.  Anatomic Challenges In Pediatric Catheter Ablation.

Authors:  Thomas A Pilcher Md; Elizabeth V Saarel Md
Journal:  J Atr Fibrillation       Date:  2014-08-31

6.  Transcatheter cryoablation with 3-D mapping of an atrial ectopic tachycardia in a pediatric patient with tachycardia induced heart failure.

Authors:  Nicholas H Von Bergen; Hadi Abu Rasheed; Ian H Law
Journal:  J Interv Card Electrophysiol       Date:  2007-05-23       Impact factor: 1.900

7.  Pseudo cryomapping for ablation of atrioventricular nodal reentry tachycardia: A single center North American experience.

Authors:  Vaibhav K Moondra; Mark L Greenberg; Barbara R Gerling; Peter T Holzberger; Steven N Weindling; Rajbir S Sangha
Journal:  Indian Pacing Electrophysiol J       Date:  2017-01-06

8.  Cryoablation time-dependent dose-response effect at minimal temperatures (-80 degrees C): an experimental study.

Authors:  Felipe Atienza; Jesús Almendral; Damián Sánchez-Quintana; Matilde Zaballos; Margarita Murillo; Concepción Jimeno; Verónica Parra; Francisco Fernández-Avilés
Journal:  Europace       Date:  2009-10-20       Impact factor: 5.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.